Clinical Trial

24-h Energy Expenditure and Anti-obesity Medication

Study acronym: SEM-TIR
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 5, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study investigates the long-term effects of anti-obesity medications (Semaglutide and Tirzepatide) on energy metabolism (24-hour energy expenditure and substrate oxidation) and body composition via Dual-energy X-ray absorptiometry (DXA)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-18.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-04-28
Trial Details
NCT Number NCT07041983
Lead Sponsor University of Pisa
Conditions Obesity
Enrollment 30 participants
Start Date 2025-07-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-05